OpenBilldrug price receipt

NADAC week of 2026-10-14

AMETHYST 90-20 MCG TABLET

FDA nonproprietary name: levonorgestrel and ethinyl estradiol

For 30 tablets

Pharmacies pay

$34.07 filed

30 × $1.13572 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$39.19 filed

30 × $1.30648 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.2× estimated

Medicare paid 1.2× what pharmacies pay.

Part D averages every strength and form sold under “Amethyst” / “Levonorgestrel/Ethin.Estradiol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$44.18 estimated

$34.07 + $5.11 (15%) + $5.00 fee per fill = $44.18

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AMETHYST 90-20 MCG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as levonorgestrel and ethinyl estradiol, under the trade name “Amethyst”.

FDA gives its dosage form as tablet and its route as oral.

The labeler, the company named on the label, is Teva Pharmaceuticals, Inc.

FDA lists it under 3 Established Pharmacologic Classes: Estrogen, Progestin and Progestin-containing Intrauterine System.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00480-3472-24.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $34.07 for 30 tablets (30 × $1.13572 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

22 other products in the NADAC file share the FDA nonproprietary name levonorgestrel and ethinyl estradiol with AMETHYST 90-20 MCG TABLET.

ProductPharmacies pay per unitMedicare per unit
ALTAVERA-28 TABLET
generic · kit
$0.11352 per EA filed
eff. 2026-09-23
$0.35078 per EA filed
Part D 2024 average
AMETHYST 90-20 MCG TABLET this page
generic · tablet
$1.13572 per EA filed
eff. 2026-09-23
$1.30648 per EA filed
Part D 2024 average
AUBRA EQ-28 TABLET
generic · kit
$0.15354 per EA filed
eff. 2026-09-23
$0.40572 per EA filed
Part D 2024 average
AVIANE-28 TABLET
generic · kit
$0.15354 per EA filed
eff. 2026-09-23
$0.38721 per EA filed
Part D 2024 average
AYUNA-28 TABLET
generic · kit
$0.11352 per EA filed
eff. 2026-09-23
We don’t know yet
BALCOLTRA TABLET
brand · kit
$10.03814 per EA filed
eff. 2026-01-01
$9.45799 per EA filed
Part D 2024 average
CHATEAL EQ-28 TABLET
generic · kit
$0.11352 per EA filed
eff. 2026-09-23
$0.4374 per EA filed
Part D 2024 average
DAYSEE 0.15-0.03-0.01 MG TAB
generic · kit
$0.12477 per EA filed
eff. 2026-09-23
$0.58271 per EA filed
Part D 2024 average
DOLISHALE 90-20 MCG TABLET
generic · tablet
$1.13572 per EA filed
eff. 2026-09-23
$1.1421 per EA filed
Part D 2024 average
FALMINA-28 TABLET
generic · kit
$0.15354 per EA filed
eff. 2026-09-23
$0.39865 per EA filed
Part D 2024 average
KURVELO-28 TABLET
generic · kit
$0.11352 per EA filed
eff. 2026-09-23
$0.38666 per EA filed
Part D 2024 average
LESSINA-28 TABLET
generic · kit
$0.15354 per EA filed
eff. 2026-09-23
$0.38762 per EA filed
Part D 2024 average
LEVONEST-28 TABLET
generic · kit
$0.32363 per EA filed
eff. 2026-09-23
$0.56482 per EA filed
Part D 2024 average
LEVONOR-ETH ESTRA 0.09-0.02 MG
generic · tablet
$1.13572 per EA filed
eff. 2026-09-23
We don’t know yet
LEVONOR-ETH ESTRAD 0.1-0.02 MG
generic · kit
$0.15354 per EA filed
eff. 2026-09-23
We don’t know yet
LEVONOR-ETH ESTRAD TRIPHASIC
generic · kit
$0.32363 per EA filed
eff. 2026-09-23
We don’t know yet
LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET
generic · kit
$0.22674 per EA filed
eff. 2026-09-23
We don’t know yet
LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB
generic · kit
$3.44543 per EA filed
eff. 2026-09-23
We don’t know yet
MARLISSA-28 TABLET
generic · kit
$0.11352 per EA filed
eff. 2026-09-23
$0.37153 per EA filed
Part D 2024 average
PORTIA-28 TABLET
generic · kit
$0.11352 per EA filed
eff. 2026-09-23
$0.34264 per EA filed
Part D 2024 average
SETLAKIN 0.15 MG-0.03 MG TAB
generic · kit
$0.22674 per EA filed
eff. 2026-09-23
$0.50192 per EA filed
Part D 2024 average
TYBLUME 0.1-0.02 MG CHEW TAB
brand · kit
$0.82769 per EA filed
eff. 2026-09-23
$0.77059 per EA filed
Part D 2024 average
VIENVA-28 TABLET
generic · kit
$0.15354 per EA filed
eff. 2026-09-23
$0.37383 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $1.13572 per EA filed.

Of the 104 other products in FDA’s Estrogen class priced per EA, 77 have a higher middle NADAC price and 25 a lower one; 2 have the same. The one in the middle is DOTTI 0.0375 MG PATCH, at $8.26227 per EA filed (eff. 2026-09-23).

Of the 65 other products in FDA’s Progestin class priced per EA, 26 have a higher middle NADAC price and 37 a lower one; 2 have the same. The one in the middle is NORETHIN-ETH ESTRAD 1 MG-5 MCG, at $0.57994 per EA filed (eff. 2026-09-23).

Of the 9 other products in FDA’s Progestin-containing Intrauterine System class priced per EA, 7 have a higher middle NADAC price and 0 a lower one; 2 have the same. The one in the middle is MY WAY 1.5 MG TABLET, at $6.33055 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $39.19 for 30 tablets, at an average of $1.30648 per EA in 2024 (2024-01-01 to 2024-12-31) for “Amethyst” and “Levonorgestrel/Ethin.Estradiol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 499 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for AMETHYST 90-20 MCG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Amethyst / Levonorgestrel/Ethin.Estradiol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.